Comparison of Enoxaparin Versus Heparin During Elective Percutaneous Coronary Intervention Performed With Either Eptifibatide or Tirofiban (The ACTION Trial)
Authors:
- Mina MadanMMMina Madan
- Shyam RadhakrishnanSRShyam Radhakrishnan
- Marciano ReisMRMarciano Reis
- Fran L. Paradiso-HardyFPFran L. Paradiso-Hardy
- Maggie Godin-EdgecombeMGMaggie Godin-Edgecombe
- Catherine SparlingCSCatherine Sparling
- Anne Marie PhillipsAPAnne Marie Phillips
- Shamila ShanmugasegaramSSShamila Shanmugasegaram
- Stephen FortSFStephen Fort
- Salim Z. NaqviSNSalim Z. Naqvi
- Eric A. CohenECEric A. Cohen
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (11) , 1295-1301
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor EptifibatideCirculation, 2003
- Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II studyAmerican Heart Journal, 2002
- Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2001
- Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina PectorisCirculation, 2001
- Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trialThe Lancet, 2000
- Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectorisThe American Journal of Cardiology, 1999
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993